Midlife Risk Factors for Impaired Physical and Cognitive Functioning at Older Ages: A Cohort Study

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 72, Issue 2, 2017, Pages 237-242

  Brunner, Eric J ^a   Welch, Catherine A ^a   Shipley, Martin J ^a   Ahmadi Abhari, Sara ^a   Singh Manoux, Archana ^a,b   Kivimäki, Mika ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HÔPITAL PAUL BROUSSE   (France)

Author keywords

Aging; Cognitive functioning; Life course; Physical functioning

Indexed keywords

AGE; AGED; COGNITION DISORDERS; COHORT ANALYSIS; DAILY LIFE ACTIVITY; FEMALE; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; AGE FACTORS; AGED; AGED, 80 AND OVER; COGNITION DISORDERS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 85022135784     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glw092     Document Type: Article

References (35)

1. Fries JF, Bruce B, Chakravarty E. Compression of morbidity 1980-2011: A focused review of paradigms and progress. J Aging Res. 2011;2011:261702. doi:10.1155/2012/420637
2. McGuinness B, Todd S, Passmore P, Bullock R. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev. 2009:CD004034. doi:10.1002/14651858.CD004034
3. Hamer M, Chida Y. Physical activity and risk of neurodegenerative disease: A systematic review of prospective evidence. Psychol Med. 2009;39:3-11. doi:10.1017/S0033291708003681
4. World Health Organization. International Classification of Functioning, Disability and Health. Geneva, Switzerland: World Health Organization; 2001.
5. Akbaraly TN, Kivimaki M, Shipley MJ, et al. Metabolic syndrome over 10 years and cognitive functioning in late midlife: The Whitehall II study. Diabetes Care. 2010;33:84-89. doi:10.2337/dc09-1218
6. Ganguli M, Fu B, Snitz BE, et al. Vascular risk factors and cognitive decline in a population sample. Alzheimer Dis Assoc Disord. 2014;28:9-15. doi:10.1097/WAD.0000000000000004
7. Sabia S, Elbaz A, Britton A, et al. Alcohol consumption and cognitive decline in early old age. Neurology. 2014;82:332-339. doi:10.1212/ WNL.0000000000000063
8. Singh-Manoux A, Marmot MG, Glymour M, Sabia S, Kivimaki M, Dugravot A. Does cognitive reserve shape cognitive decline? Ann Neurol. 2011;70:296-304. doi:10.1002/ana.22391
9. Marmot M, Brunner E. Cohort profile: The Whitehall II study. Int J Epidemiol. 2005;34:251-256. doi:10.1093/ije/dyh372
10. Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist. 1970;10:20-30. doi:10.1093/geront/10.1-Part-1.20
11. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198. doi:10.1016/0022-3956(75) 90026-6
12. Kukull WA, Larson EB, Teri L, Bowen J, McCormick W, Pfanschmidt ML. The Mini-Mental State Examination score and the clinical diagnosis of dementia. J Clin Epidemiol. 1994;47:1061-1067. doi:10.1016/0895-4356(94)90122-8
13. Taylor HL, Jacobs DR Jr, Schucker B, Knudsen J, Leon AS, Debacker G. A questionnaire for the assessment of leisure time physical activities. J Chronic Dis. 1978;31:741-755. doi:10.1016/0021-9681(78)90058-9
14. Goldberg DP. The Detection of Psychiatric Illness by Questionnaire. Oxford, UK: Oxford University Press; 1972. ISBN:0-197-12143-8
15. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319-338. doi:10.1183/09031936.05.00034805
16. Xu X, Laird N, Dockery DW, Schouten JP, Rijcken B, Weiss ST. Age, period, and cohort effects on pulmonary function in a 24-year longitudinal study. Am J Epidemiol. 1995;141:554-566.
17. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: Wiley; 1987. ISBN:0-471-65574-0
18. Carpenter J, Kenward M. Multiple Imputation and its Applications. Chichester, UK: Wiley; 2013. ISBN:978-0-470-74052-1
19. National Institute for Health and Care Excellence. Dementia, Disability and Frailty in Later Life Mid-life Approaches to Delay or Prevent Onset. NG16. London, UK: National Institute for Health and Care Excellence; 2015.
20. Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial. Lancet. 2015;385:2255-2263. doi:10.1016/S0140-6736(15)60461-5
21. Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer s disease: An analysis of population-based data. Lancet Neurol. 2014;13:788-794. doi:10.1016/ S1474-4422(14)70136-X
22. Richards M, Strachan D, Hardy R, Kuh D, Wadsworth M. Lung function and cognitive ability in a longitudinal birth cohort study. Psychosom Med. 2005;67:602-608. doi:10.1097/01.psy.0000170337.51848.68
23. Beydoun MA, Beydoun HA, Gamaldo AA, Teel A, Zonderman AB, Wang Y. Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-Analysis. BMC Public Health. 2014;14:643. doi:10.1186/1471-2458-14-643
24. Sabia S, Elbaz A, Dugravot A, et al. Impact of smoking on cognitive decline in early old age: The Whitehall II cohort study. Arch Gen Psychiatry. 2012;69:627-635. doi:10.1001/archgenpsychiatry.2011.2016
25. Emmerzaal TL, Kiliaan AJ, Gustafson DR. 2003-2013: A decade of body mass index, Alzheimer s disease, and dementia. J Alzheimers Dis. 2015;43:739-755. doi:10.3233/JAD-141086
26. Qizilbash N, Gregson J, Johnson ME, et al. BMI and risk of dementia in two million people over two decades: A retrospective cohort study. Lancet Diabetes Endocrinol. 2015;3:431-436. doi:10.1016/S2213-8587(15)00033-9
27. Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF 3rd. Late-life depression and risk of vascular dementia and Alzheimer s disease: systematic review and meta-Analysis of community-based cohort studies. Br J Psychiatry. 2013;202:329-335. doi:10.1192/bjp.bp.112.118307
28. Gallagher D, Kiss A, Lanctot K, Herrmann N. Depressive symptoms and cognitive decline: A longitudinal analysis of potentially modifiable risk factors in community dwelling older adults. J Affect Disord. 2016;190:235-doi:10.1016/j.jad.2015.09.046
29. Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci. 2000;55:M709-M715. doi:10.1093/ gerona/55.12.M709
30. Batty GD, Shipley M, Tabak A, et al. Generalizability of occupational cohort study findings. Epidemiology. 2014;25:932-933. doi:10.1097/ EDE.0000000000000184
31. Fujiwara Y, Yoshida H, Amano H, et al. Predictors of improvement or decline in instrumental activities of daily living among community-dwelling older Japanese. Gerontology. 2008;54:373-380. doi:10.1159/000151221
32. Sabia S, Singh-Manoux A, Hagger-Johnson G, Cambois E, Brunner EJ, Kivimaki M. Influence of individual and combined healthy behaviours on successful aging. CMAJ. 2012;184:1985-1992. doi:10.1503/cmaj.121080
33. Van Beijsterveldt CE, van Boxtel MP, Bosma H, Houx PJ, Buntinx F, Jolles J. Predictors of attrition in a longitudinal cognitive aging study: The Maastricht Aging Study (MAAS). J Clin Epidemiol. 2002;55:216-223. doi:10.1016/S0895-4356(01)00473-5
34. Benjamini Y, Hochberg Y. Controlling the false discovery rate a practical and powerful approach to multiple testing. J R Stat Soc B Methodological. 1995;57:289-300.
35. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer s disease prevalence. Lancet Neurol. 2011;10:819-828. doi:10.1016/ S1474-4422(11)70072-2